HopeStage
Back to all studies
CompletedNCT06282146

Personalized magnetic stimulation target for depression

About this titleRead the official source — NCT06282146
Interventional studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: September 9, 2024
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
Brigham and Women's Hospital
Sponsor type
Hospital / academic medical center
Study type
Procedure
Intervention type
Procedure
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06282146
Official title
Show the full official title

Testing a Transdiagnostic TMS Treatment Target

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies